Medesis Pharma (France) Probability of Future Stock Price Finishing Over 0.56

ALMDP Stock  EUR 0.35  0.01  2.94%   
Medesis Pharma's future price is the expected price of Medesis Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Medesis Pharma SA performance during a given time horizon utilizing its historical volatility. Check out Medesis Pharma Backtesting, Medesis Pharma Valuation, Medesis Pharma Correlation, Medesis Pharma Hype Analysis, Medesis Pharma Volatility, Medesis Pharma History as well as Medesis Pharma Performance.
  
Please specify Medesis Pharma's target price for which you would like Medesis Pharma odds to be computed.

Medesis Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medesis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medesis Pharma SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Medesis Pharma SA generated a negative expected return over the last 90 days
Medesis Pharma SA has high historical volatility and very poor performance
Medesis Pharma SA has some characteristics of a very speculative penny stock
The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0.
About 17.0% of the company shares are held by company insiders

Medesis Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medesis Stock often depends not only on the future outlook of the current and potential Medesis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medesis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.4 M
Cash And Short Term Investments2.9 M

Medesis Pharma Technical Analysis

Medesis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Medesis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medesis Pharma SA. In general, you should focus on analyzing Medesis Stock price patterns and their correlations with different microeconomic environments and drivers.

Medesis Pharma Predictive Forecast Models

Medesis Pharma's time-series forecasting models is one of many Medesis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medesis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Medesis Pharma SA

Checking the ongoing alerts about Medesis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medesis Pharma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Medesis Pharma SA generated a negative expected return over the last 90 days
Medesis Pharma SA has high historical volatility and very poor performance
Medesis Pharma SA has some characteristics of a very speculative penny stock
The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0.
About 17.0% of the company shares are held by company insiders

Additional Tools for Medesis Stock Analysis

When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.